The Federal Trade Commission's opinion earlier this year in In the Matter of POM Wonderful emphasizes the importance of food and dietary supplement manufacturers and marketers paying close attention to whether their products' claims of health benefits are permitted by the FTC and backed by sufficient scientific support.
The POM opinion highlights the risks of explicitly or impliedly making a claim that a food or dietary supplement can treat, prevent or reduce the risk of a particular disease or that such health benefits are established by clinical studies in the absence of sufficient scientific support.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
